Clinical Trial Update: NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy

View source ↗

Summary

The NORDIC trial investigating nitric oxide-derived oxidants and regional endothelial and diastolic dysfunction in dilated cardiomyopathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Snippet

Sponsor: The Cleveland Clinic | Conditions: Chronic Systolic Heart Failure (Dilated Cardiomyopathy) | Status: TERMINATED